Friday, January 16 andSaturday, January 17, 2009

Course DirectorsHarvey A. Lincoff, M.D.Lawrence A. Yannuzzi, M.D.

Program CommitteeK. Bailey Freund, M.D.Jason S. Slakter, M.D.Richard F. Spaide, M.D.

Honorees:Thomas M. Aaberg, Sr., M.D.D. Jackson Coleman, M.D.Lee M. Jampol, M.D.

Jointly SponsoredNYU Post-Graduate Medical SchoolLenox Hill Hospital/Manhattan Eye, Ear and Throat Institute

Supported by The Macula Foundation, Inc.

GENERAL INFORMATIONOphthalmologists $400.00Residents and Fellows $50.00Registration includes continental breakfast,coffee breaks and lunch.

REFUNDSAll refund requests must be made in writingand postmarked by January 10, 2009. There isa $50.00 cancellation fee. Refunds are notpossible after the January 10, 2009 d eadline.

ACCREDITATION STATEMENTThis activity has been planned andimplemented in accordance with the EssentialAreas and policies of the Accreditation Councilfor Continuing Medical Educatio n (ACCME)through the joint sponsorship of NYU Post-Graduate Medical Schooland Lenox Hill Hospital.NYU Post-Graduate Medical School isaccredited by the ACCME to providecontinuing medical education for physicians.

CREDIT DESIGNATION STATEMENTThe NYU Post-Graduate Medical Schooldesignates this educational activity for amaximum of 11 AMA PRA Category 1Credits™. Physicians should only claim creditscommensurate with the extent of theirparticipation in the activity.

DISCLOSURE POLICY STATEMENTThe NYU Post-Graduate Medical Schooladheres to ACCME Essential Areas andpolicies, including the Standards forCommercial Support regarding industrysupport of continuing medical education. In order to resolve any identified Conflicts ofInterest, disclosure information is providedduring the planning process to ensureresolution of any identified conflicts.Disclosure of faculty and commercialrelationships as well as the discussion ofunlabeled or unapproved use of any drug,device or procedure by the faculty will be fullynoted at the meeting.

LOCATIONFellows Case Presentations Thursday, January 15, 2009, 12:30 - 5pmCorwin HallLenox Hill Hospital, Manhattan Eye, Ear and Throat Institute210 East 64th Street, New York, NY 10065

Farkas AuditoriumNew York University School of Medicine

550 1st Avenue at 30th Street,New York, NY 10016

There are several parking garages withinwalking distance.

HOTEL INFORMATIONA block of rooms has been reserved for courseparticipants. When making your reservation,please specify that you are registering for theMacula 2009 course.

The cut off date for reservations is December 25, 2008

Affinia Gardens Affinia Dumont215 East 64th Street 150 East 34th Street

Phone: 866-233-4642Outside USA: 212-320-8050

reservations@affinia.com

Hotel Plaza Athenee37 East 64th Street

Reservations: Anne-Marie Pinsault212-606-4662

ampinsault@plaza-athenee.com

Questions212-605-3777

mertz@retinal-research.org

Organizational CommitteeDavid Abramson, M.D.Ronald Carr, M.D.Stanley Chang, MDDonald D’Amico, M.D.Harry Engel, M.D.Yale Fisher, M.D.Douglas Jabs, M.D.Kenneth Noble, M.D.Joesph Walsh, M.D.Marco Zarbin, M.D.The LuEsther T. Mertz

Retinal Research Center

Host CommitteeAlexander Aizman, M.D.Rando Allikmets, M.D.Gaetano Barile, M.D.Scott Brodie, M.D.Frank Cangemi, M.D.Paul Chan, M.D.Michael Cooney, M.D.Lucian Del Priore, M.D.David Fastenberg, M.D.Phillip Ferrone, M.D.John Flynn, M.D.Paul Finger, M.D.Wayne Fuchs, M.D.Ronald Gentile, M.D.Vincent Giovinazzo, M.D.James Klancnik, Jr., M.D.Richard Klein, M.D.Carol Lee, M.D.Francis L’Esperance, M.D.Hilel Lewis, M.D.Thomas Muldoon, M.D.Jeffrey Paccione, M.D.Richard Rosen, M.D.Daniel Roth, M.D.C. Michael Samson, M.D.William Schiff, M.D.Eric Schrier, M.D.Hermann Schubert, M.D.Eric Shakin, M.D.Jeffrey Shakin, M.D.Belinda Shirkey, M.D.R. Theodore Smith, M.D.Harold Spalter, M.D.Janet Sparrow, M.D.John Sorenson, M.D.Stephen Tsang, M.D.Kenneth Wald, M.D.Matthew Wheatley, M.D.

Dennis Orlock, CRA

COURSE DESCRIPTIONUsing a combination of didactic lectures anddiscussions, faculty members will present advances indiagnosis and treatment of macular diseases to fellowophthalmologists. The eleven hour course will discussalternative concepts for “dry” and “wet” age-relatedmacular degeneration, including a discussion on thebasic science behind the disease, diabetic retinopathy,idiopathic perifoveal telangetasia, ocular tumors, aswell as other vitreo-retina macular diseases.Information on new and experimental pharmacologicaltherapies, as well as new imaging concepts,vitreoretinal surgical instrumentation and applicationswill also be presented. At the completion of this course, participants will havea thorough understanding of the latest advances in themanagement of macular diseases. Participants will alsohave an increased knowledge of new imaging anddiagnostic techniques available to the ophthalmiccommunity, as well as the decision making processutilized by the course faculty in approaching these situations.

EDUCATIONAL OBJECTIVES• Discuss new imaging technology

(e.g. spectral OCT, Autofluorescence) in the diagnosis of retina and macular diseases.

• Assess and evaluate the latest developments of vitreous, retina and macular diseases, as well as ocular tumors.

• Assess and evaluate the latest developments in pharmacotherapuetic treatments for AMD and other macular diseases.

• Assess and evaluate the latest developments in surgical trends, including small vitrectomy surgery and wound healing.

TARGET AUDIENCEOur audience consists of ophthalmologists with aninterest in the management of vitreous, retina andmacular disease. New information is best disseminatedthrough interactive lectures, discussions and questionand answer sessions.

STATEMENT OF NEEDThe leading cause of legal blindness in the UnitedStates is macular disease, a term which includes age-related macular degeneration (AMD) and diabeticretinopathy. AMD afflicts approximately 10 millionAmericans. Pharmacological treatment for AMD hasbecome a billion dollar business and healthcareexpenditures for ophthalmic procedures haveskyrocketed. In addition, with diabetes on the rise,millions more will need comprehensive eye care. Asthe U.S. population continues to age, it is important thatophthalmologists continue to be updated on theadvances in cost effective treatme nt and managementof vitreous, retina and macular disease.

Atlantic CoastRetinal Club

Meeting Friday, January 16, 2009

7:30am - 12:00pm

Macula 2009Friday, January 16, 2009

1:00 - 5:00pmSaturday, January 17, 2009

7:00am - 5:30pm

Saturday, January 17, 20096:30 - 7:00am Breakfast • Registration7:00 - 7:15am Welcome: Jack Dodick, M.D.

Introduction: Harvey Lincoff, M.D.Lawrence Yannuzzi, M.D.

7:15 - 8:15am Ophthalmic Technology Chairman: Professor Rosario BrancatoModerator: D. Jackson Coleman, M.D.

MicroPerimetry and Imaging Correlates Richard Rosen, M.D.

Ocular UltrasoundPaul Chan, M.D.

New Perspectives in Fundus AutofluorescenceFrank Holz, M.D.

Erythrocyte Movement in the CapillariesRobert Flower, Ph.D.

Drug DeliveryKarl Csaky, M.D.

Developments in Ocular Drug DeliveryWilliam Mieler, M.D.

8:15 - 9:45am OCT ImagingChairman: Gabriel Coscas, M.D.Moderator: Carmen Puliafilto, M.D.

Spectral Domain OCT of Dry AMDPhil Rosenfeld, M.D.

Automated Drusen Detection with Spectral Domain 3D OCT

Yale Fisher, M.D.Secret Life of Drusen

Cynthia Toth, M.D.Fundus and SD-OCT Imaging

Giovanni Staurenghi, M.D.Diabetic Macular Edema Phenotypes: The Imaging Approach

Eduordo Midena, M.D.Choroidal Imaging with OCT

Richard Spaide, M.D.OCT and Epiretinal Surgery

John Thompson, M.D.Spectral Domain OCT Artifacts

Glenn Jaffe, M.D.

9:45 - 10:15am Coffee Break • Exhibits10:15 -11:15am Medical Retina

Chairman: Joesph Walsh, M.D.Moderator: Robert Murphy, M.D.

Management of Posterior UveitisDouglas Jabs, M.D.

Update on Mifepristone Therapy of Central Serous Chorioretinopathy

Lee Jampol, M.D.

A Syndrome Resembling APMPPE in Older Patients

Mark Johnson, M.D.New Concepts in Retinal Neuroprotection

George Williams, M.D.Endophthalmitis After Intravitreal Injections

Harry Flynn, M.D.Nmo, Crmp, Vkh-Ying Yang

Jose Pulido, M.D.Macular Telangiectasia Type II

Lawrence Yannuzzi, M.D.

11:15 - 12:30pm Retinal VascularChairman: William Tasman, M.D.Moderator: Hermann Schubert, M.D.

Advances in Diabetic PharmacotherapeuticsMichael Cooney, M.D.

READ 2 Trial – Ranibizumab forTreatment of DME

Quan Dong Nguyen, M.D.Treatment of Diabetic Macular Edemawith Topical Mecamylamine

Peter Campochiaro, M.D.Ranibizumab Dose Comparison in theTreatment of DME

Phillip Ferrone, M.D.Vitrectomy for DME: the DRCRNetwork Results

Julia Haller, M.D.Diabetic Retinopathy Progress AfterCataract Surgery?

Neil Bressler, M.D.The Vitreous and Retinal Vascular Disease

Michael Trese, M.D.Ranibizumab for Ischemic CRVO

David Brown, M.D.

12:30 - 1:30pm Lunch • Exhibits

1:30 - 2:30pm Surgical RetinaChairman: Morton Goldberg, M.D.Moderator: Gary Abrams, M.D.

Vitrectomy for Retinoschisis/Detachment inHigh Myopia

Stanley Chang, M.D.Microincision Pars Plana Vitrectomy

Allen Ho, M.D.25 Gauge Macular Surgery Update

Steven Charles, M.D.Why Macular Holes Close: a Working Hypothesis

Mark Blumenkranz, M.D.Mysteries Regarding the Surgically Reattached Macula

C. Pat Wilkinson, M.D.Complicated Retinal Detachment with Permanent Keratoprosthesis

Donald D’Amico, M.D.

2:30 - 3:30pm Dry AMD Chairman: Gisele Soubrane, M.D.Moderator: Lawrence Singerman, M.D.

New Findings on Geographic Atrophy from AREDS

Frederick Ferris, M.D.Genetics of Geographic Atrophy in AMD

Kang Zhang, M.D.Cataract Surgery for AMD Patients

Emily Chew, M.D.AMD After Cataract Surgery

Susan Bressler, M.D.Pharmacological Vitreolysing in AMD

Lucian Del Priore, M.D.Therapeutic Strategies for Dry AMD

Jason Slakter, M.D.Current Treatment for Dry AMD

James Klancnik Jr., M.D.

3:30 - 4:00pm Coffee Break • Exhibits4:00 - 5:00pm Neovascular AMD

Chairman: Thomas Aaberg Sr., M.D.Moderator: Mark Blumenkranz, M.D.

Classification for Neovasularization and its Relevance?

K. Bailey Freund, M.D.Therapeutic Intraocular Levels of VEGF and Cytokines.

Ursula Schmidt-Erfurth, M.D.Treat and Extend

Carl Regillo, M.D.VEGF Trap-Eye for Exudative AMD

Jeffrey Heier, M.D.Combination Treatment for AMD

Peter Kaiser, M.D.Update on the Comparison of AMD Treatment Trials

Daniel Martin, M.D.

5:00 - 5:30pm AMD PanelK. Bailey Freund, M.D. Jeffrey Heier, M.D.Peter Kaiser, M.D.Daniel Martin, M.D.Carl Regillo, M.D.Phillip Rosenfeld, M.D. Ursula Schmidt-Erfurth, M.D. Jason Slakter, M.D.Richard Spaide, M.D.

5:30pmMeeting AdjournmentHarvey Lincoff, M.D. Lawrence Yannuzzi, M.D.

Lu

Est

her

T.

Mer

tz R

etin

al R

esea

rch

Cen

ter

Man

hat

tan

Eye

, E

ar &

Th

roat

In

stit

ute

210

Eas

t 64

th S

tree

t, 8

th F

loo

rN

ew Y

ork

, N

Y 1

0065

Mak

e ch

ecks

pay

able

to:

LHH

/MEE

TI -

MA

CU

LA 2

009

Mac

ula

2009

Thur

sday

, Jan

uary

15;

Frid

ay, J

anua

ry 1

6 an

d S

atur

day

, Jan

uary

17,

200

9R

egis

trat

ion

Fee

Enc

lose

d(c

ircle

one

):O

pht

halm

olog

ist

$ 400

.00

Res

iden

ts a

nd F

ello

ws

$ 50.

00*

*Reg

istr

atio

n m

ust

incl

ude

lett

er fr

om C

hairm

an c

ertif

ying

Fel

low

ship

or R

esid

ency

sta

tus.

Reg

istr

atio

n in

clud

es c

ontin

enta

l bre

akfa

st,

coff

ee b

reak

s an

d lu

nch.

SE

ND

TH

E C

OM

PLE

TED

RE

GIS

TRA

TIO

N F

OR

MW

ITH

YO

UR

CH

EC

K T

O:

Mic

helle

Cim

ino

LuE

sthe

r T.

Mer

tz R

etin

al R

esea

rch

Cen

ter

Man

hatt

an E

ye, E

ar &

Thr

oat

Inst

itute

210

Eas

t 64

th S

tree

t, 8t

h Fl

oor

New

Yor

k, N

Y 1

0065

Do

yo

u p

lan t

o a

tte

nd

the

Atla

ntic

Co

ast

Me

eting

on F

rid

ay,

Ja

nua

ry 1

6, 2

00

9?

REG

ISTR

ATIO

N C

AR

D

Nam

e

Add

ress

Pho

neFa

x

Yes

No

Friday, January 16, 200912:30 - 1:00pm Registration1:00 - 1:05pm Introduction

Lawrence Yannuzzi, M.D.

1:05 - 2:00pm Ocular OncologyChairman: David Abramson, M.D.Moderator: Evan Gragoudas, M.D.

9 Pearls in the Diagnosis of Uveal MelanomaJerry Shields, M.D.

9 Pearls in the Treatment of Uveal MelanomaCarol Shields, M.D.

New Molecular Targets for Uveal MelanomaGary Schwartz, M.D.

Principles of Radiation for the Retina MDPaul Finger, M.D.

Retinoblastoma: DiagnosisBrian Marr, M.D.

Retinoblastoma: New Treatments Now and Future David Abramson, M.D.

2:00 - 2:30pm The Fund For Ophthalmic Knowledge Lectureship

New Molecular Observations in Melanoma:William Harbour, M.D.

2:30 - 3:00pm HONOREESIntroduction: Harvey Lincoff, M.D.

Thomas Aaberg, Sr., M.D. Presented by Gary Abrams, M.D.

D. Jackson Coleman, M.D.Presented by Stanley Chang, M.D.

Lee Jampol, M.D. Presented by Morton Goldberg, M.D.

3:00 - 3:30pm Coffee Break • Exhibits3:30 - 4:30pm Hereditary Disease

Chairman: Ronald Carr, M.D.Moderator: Kenneth Noble, M.D.

Genetic Basis of AMD and Related DisordersRando Allikmets, M.D.

Aberrant Complement Activation in AMDGreg Hageman, M.D.

AMD: Nature and Nurture-Genes and EnvironmentJohanna Seddon, M.D.

Rescue by Gene Therapy and Gene SilencingStephen Tsang, M.D.

Fundus AlbipunctatusGraham Holder, M.D.

Developmental Disorders of the MaculaTony Moore, M.D.

4:30 - 5:00pm The Cecilia and Paul J. SchupfLighthouse International Lectureship

The Role of Retinal Pigment Epithelial Dysfunction in Retinal Disease:

Alan Bird, M.D.

MACULA 2009

/ColorImageDict > /JPEG2000ColorACSImageDict > /JPEG2000ColorImageDict > /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 300 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 300 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict > /GrayImageDict > /JPEG2000GrayACSImageDict > /JPEG2000GrayImageDict > /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 1200 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages true /MonoImageDownsampleType /Bicubic /MonoImageResolution 1200 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict > /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile () /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False

/Description > /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ > /FormElements false /GenerateStructure true /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles true /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /NA /PreserveEditing true /UntaggedCMYKHandling /LeaveUntagged /UntaggedRGBHandling /LeaveUntagged /UseDocumentBleed false >> ]>> setdistillerparams> setpagedevice